Needham & Company LLC Reaffirms “Hold” Rating for Cardlytics (NASDAQ:CDLX)

Cardlytics (NASDAQ:CDLX)‘s stock had its “hold” rating reiterated by research analysts at Needham & Company LLC in a research report issued on Thursday,Benzinga reports.

Cardlytics Price Performance

Shares of CDLX opened at $2.47 on Thursday. Cardlytics has a 12-month low of $1.77 and a 12-month high of $20.52. The business has a 50-day simple moving average of $3.02 and a two-hundred day simple moving average of $3.50. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. The stock has a market cap of $125.53 million, a PE ratio of -0.40 and a beta of 1.62.

Insider Buying and Selling at Cardlytics

In other Cardlytics news, CEO Amit Gupta sold 15,160 shares of the company’s stock in a transaction dated Friday, January 24th. The stock was sold at an average price of $3.92, for a total value of $59,427.20. Following the sale, the chief executive officer now owns 215,494 shares in the company, valued at approximately $844,736.48. The trade was a 6.57 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Alexis Desieno sold 24,778 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the completion of the sale, the chief financial officer now owns 140,948 shares in the company, valued at $479,223.20. This trade represents a 14.95 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 111,454 shares of company stock worth $391,864. Insiders own 4.40% of the company’s stock.

Institutional Investors Weigh In On Cardlytics

Several institutional investors and hedge funds have recently made changes to their positions in the business. Intech Investment Management LLC boosted its position in shares of Cardlytics by 31.3% during the 4th quarter. Intech Investment Management LLC now owns 19,310 shares of the company’s stock valued at $72,000 after purchasing an additional 4,607 shares in the last quarter. Check Capital Management Inc. CA boosted its holdings in Cardlytics by 10.4% in the third quarter. Check Capital Management Inc. CA now owns 50,650 shares of the company’s stock worth $162,000 after acquiring an additional 4,775 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in Cardlytics by 32.1% in the third quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock worth $63,000 after acquiring an additional 4,796 shares in the last quarter. SG Americas Securities LLC boosted its holdings in Cardlytics by 38.2% in the fourth quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock worth $72,000 after acquiring an additional 5,392 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its holdings in Cardlytics by 46.0% in the fourth quarter. Wells Fargo & Company MN now owns 21,106 shares of the company’s stock worth $78,000 after acquiring an additional 6,649 shares in the last quarter. Institutional investors own 68.10% of the company’s stock.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.